| abstract |
A polymeric drug device unit comprising: (i) a polyurethane block copolymer obtainable by co-reacting: (a) a poly(alkylene oxide); (b) a difunctional compound; (c) a difunctional isocyanate; and (d) optionally a block copolymer comprising poly(alkylene oxide) blocks; and (ii) a pharmaceutically active agent, wherein the pharmaceutically active agent is selected from the group consisting of quinagolide, quinagolide N-desethyl metabolite, and quinagolide N,N-dideethyl metabolite, or a pharmaceutically acceptable salt thereof. . |